SS Innovations International (NASDAQ: SSII) is building momentum for its SSi Mantra surgical robotic system, with growing utilization in India providing a foundation for broader international expansion. The company reported that more than 50 robotic procedures were performed with the system in a single day at Mohak Bariatrics and Robotics in Indore, demonstrating the platform's capacity for high-volume clinical use.
The company also reported 224 SSi Mantra systems installed across 12 countries and a 143% year-over-year increase in robotic procedures during the second quarter of 2026. Quarterly revenue rose 39% to $13.9 million, with system sales increasing 41% to $12.4 million, while installations reached 30 systems during the quarter.
India remains the company's primary commercial market, but SS Innovations is also pursuing regulatory expansion into Europe and the United States. CE marking is targeted for the end of 2026, and FDA review of its 510(k) application is now expected by the end of the first quarter of 2027. The company is also developing telesurgery capabilities and expanding surgeon training as it seeks to grow utilization and establish its platform in additional markets.
For investors, the numbers suggest that SS Innovations is moving from early adoption to broader commercialization. The 143% jump in procedures indicates that installed systems are being used more intensively, which can drive recurring revenue from instruments and services. The 39% revenue growth and 41% increase in system sales show that demand for the SSi Mantra remains strong, even as the company invests in regulatory approvals for new markets.
The push into Europe and the United States is significant because those regions represent the largest markets for surgical robotics, currently dominated by established players. If SS Innovations secures CE marking and FDA clearance, it could offer a more affordable alternative, potentially expanding access to robotic surgery in cost-sensitive healthcare systems. The company's focus on telesurgery could also open new use cases, such as remote procedures in underserved areas.
To view the full article, visit https://ibn.fm/6FPBS. The latest news and updates relating to SSII are available in the company's newsroom at https://ibn.fm/SSII.
About SS Innovations International Inc. SS Innovations International develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The company's product range includes its proprietary "SSi Mantra" surgical robotic system and its comprehensive suite of "SSi Mudra" surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.
About TechMediaWire TechMediaWire ("TMW") is a specialized communications platform with a focus on pioneering public and private companies driving the future of technology. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today's market, TMW brings its clients unparalleled recognition and brand awareness. TMW is where breaking news, insightful content and actionable information converge.
Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://www.TechMediaWire.com/Disclaimer.
